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 Cannabinoid receptors have great therapeutic potential and are important targets in drug 
discovery.  As part of a broader project whose long-term goal is the determination of the basis 
for the actions of cannabinoids at the molecular level, this research project focuses on increasing 
the knowledge of the newly discovered third cannabinoid receptor, GPR55, through computer 
simulations by refining the model of the inactive (R) state of GPR55. 
In order to explore the conformational space available to specific transmembrane helices 
(TMHs) of GPR55, the Conformational Memories (CM), a computational method was used.  
CM is a Monte Carlo/Simulated Annealing (MC/SA) algorithm that can employ different 
molecular force fields.  In the first part of this work the force field employed and the starting 
structure used were varied in order to optimize the method.  This was done by exploring the 
conformational space of the second transmembrane helix (TMH2) of CB2, for which 
experimental data was available for validation.    
The GPR55 sequence exhibits many of the key sequence motifs of the Class A GPCRs 
and can therefore be easily aligned with other Class A GPCR sequences.  From this alignment 
possible flexible regions of amino acids on each helix were identified for exploration.  The 
regions were: VLSLP in TMH2, KVFFP, GFLLP, MGIMG in TMH5, VSFLP in TMH6, and 
CCLDV in TMH7.  The calculated conformational space available to these helices is of special 
importance when building the computer model of GPR55 so that the resultant model reflects the 
sequence dictated conformation of the receptor bundle.   
At the beginning of this project, rhodopsin (Rho), the prototype receptor of Class A 
GPCRs, was the only transmembrane protein for which the crystal structure has been solved.  
 
 
For this reason and because GPR55 has sufficiently sequence similarity with Rho, this receptor 
was used as a template to build an initial model presented in a poster at the 2006 International 
Cannabinoid Research Society meeting.  
The results revealed differences between the conformational tendencies of GPR55 TMHs 
compared to the template.  In the case of the TMH2 population, most helices reached over 
towards TMH3 more than rhodopsin, while TMH5 bends away from the template regardless of 
which flexible region was varied.  The results of TMH6 conformational memories showed that 
this population leaned toward the TMH5 at the extracellular end.  The present work deepens our 
understanding of the structure of GPR55 and the conformational differences between it and Rho 
that are dictated by divergences in amino acid sequence. 
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PREFACE 
As part of a broader project whose long-term goal is the determination of the basis for the 
actions of cannabinoids at the molecular level, this research project focuses on increasing the 
knowledge of the third cannabinoid receptor, GPR55, through computer simulations.  
Specifically, the work planned here will be used to refine the model of the inactive (R) state of 
GPR55. 
 
Specific Aim 1: Computational Method Optimization 
First the biased MC/SA computational method used to explore the conformational 
mobility of the receptor‟s individual helices and described in the RESEARCH AND METHODS 
section was optimized.  Variations in the force field (AMBER* or CHARMM) and in the starting 
structure employed were compared in the context of a case study about the role that TMH6 of 
CB2 has in the ligand-receptor activation and in the ligand-independent activation.  Relevant 
experimental data is available for validation. 
 
Specific Aim 2: Refinement of R State Model of GPR55 
 The initial model of GPR55 reported here in the RESULTS section was based upon a 
Rho crystal structure template, from the Protein Data Bank (1GZM structure).  Reggio and co-
workers have studied CB1/CB2 extensively in the last couple of decades and have shown that 
although the Rho crystal structure is a good starting point for the cannabinoid receptor modeling, 
there are sequence dictated differences between it and each of the cannabinoid receptors.  In the 
work reported here, the optimized MC/SA CM method was employed to study some of the 
sequence dictated differences from a Rho template in TMH2, 5, 6 and 7 of the GPR55 receptor.  
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The conformational space available to these helices due to their flexible region(s) was explored.  
From experimental data available about GPR55 interactions with other known cannabinoid 
ligands and from the results obtained, appropriate helix conformations were used in the 
refinement of an existing R state model of this receptor.  In TMH2 the flexible region from V2.54 
to P2.58 was considered.  Secondly, the conformational space allowed by possibly three regions 
of flexibility in TMH5 was explored.  These regions are: K5.37-P5.41, G5.46-P5.50, and M5.51-
G5.55.  In TMH6 the region from V6.46 to P6.50 was examined while in TMH7 the region 
between C7.46 to V7.50.  These studies should contribute to an increased understanding of the 
actions of cannabinoids at a molecular level. 
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CHAPTER I 
INTRODUCTION 
 
1.1 Membrane Protein Structure Determination 
Because membrane proteins have key biological functions such as ion transport and 
regulation, energy transduction, molecular recognition and response, they are major targets for 
many pharmacological compounds.  Therefore, determining the structure of these proteins and the 
conformational changes that occur during activation would be invaluable for developments in 
drug design.  For example, after the structure is determined, site-directed mutagenesis can be used 
to change specific aspects of the architecture of the molecule and study the resulting molecular 
structure change and correlate it with the degree of functional change.   
 Mammalian cell membranes are complex mixtures of different lipids and proteins.  The 
lipids interact with one another to form bilayers, and the proteins span the bilayers or bind to the 
outer surfaces.  Almost a quarter of the genes in most genomes encode membrane proteins 
(Yeagle and Albert 2007) and 30 percent of proteins expressed in eukaryotic cells are supposed to 
be membrane proteins (Thomas 2001).  However, in spite of the increasing number of solved 
protein structures, most of them are globular proteins and very few are integral membrane 
proteins (Yeagle and Albert 2007).  Membrane proteins are much more difficult to study than 
soluble proteins, due to the physiochemical properties that they must have in order to exist in the 
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hydrophobic environment of the lipid bilayer and the hydrophilic extra-membrane regions.  
Because of their amphipathic nature, these proteins are not soluble in aqueous solutions.  The 
majority of the methods existing today for the analysis of proteins are designed for water-soluble 
proteins.  Some of these methods include 2D polyacrylamide gel (PAGE) electrophoresis, 
capillary electrophoresis, chromatography, electron microscopy, atomic force microscopy (Engel 
and Muller 2000), matrix-assisted laser desorption/ionization (MALDI) electrospray mass 
spectrometry, 2D NMR (Thomas 2001) and X-ray crystallography.  Another crystallographic 
method, high resolution X-ray powder diffraction has also been used in the last decade to solve 
and refine protein structure (Von Dreele 1999; Von Dreele, Stephens et al. 2000).  Membrane 
proteins denature outside the membrane therefore, adaptations of these techniques to membrane 
proteins have been met with only limited success.  Detergents, which mimic the lipid bilayer, are 
used in order to solubilize membrane proteins in aqueous environments.  However, the use of 
detergents inhibits their crystallization and decreases the resolution significantly in X-ray 
crystallography, for example.  The resolution is a global measure of the model quality and ranges 
from low resolution, in which case only the general shape of the protein is revealed, to high 
resolution (1-2 Å), where most atomic positions can be detected.  Uncertainty may still be present 
even in the structures obtained at very high resolution due to the inherent mobility of amino acid 
side chains.  The most dynamic side chains will give variations in conformations that cause 
unclear images, which could be a valuable indication of where the most mobile regions are 
located. 
 In spite of the numerous obstacles that membrane proteins present when attempting to 
crystallize them, a variety of different protein modification and engineering approaches have 
contributed to recent advances in GPCR crystallography.  To date there are four inactive-state 
crystal structures of four GPCRs for comparison: the human beta 2 adrenergic ( 2-AR) receptor 
 
 
3 
bound to the high affinity inverse agonists carazolol and timolol (Rasmussen, Choi et al. 2007) 
acian beta 1 adrenergic ( 1-AR) receptor bound to the antagonist cyanopindolol (Warne, Serrano-
Vega et al. 2008) the human A2A adenosine receptor bound to the antagonist ZM241385 (Jaakola, 
Griffith et al. 2008) and bovine rhodopsin containing the covalently bound inverse agonist 11-cis 
retinal (Palczewski, Kumasaka et al. 2000). 
 Many GPCRs exhibit constitutive activity (CA), which is inhibited by inverse agonists or 
antagonists.  Constitutive activity is the biological response that is produced by receptors in the 
absence of ligand.  These ligands stabilize the ground state of the protein significantly, improving 
the chances of its crystallization.  For this reason and to gain information about the binding site 
and its interaction with a ligand, the protein is often bound to an antagonist or inverse agonist and 
stabilized in an inactive state.  This can increase the thermal stability enough that a greater variety 
of crystallization conditions may be allowed.  Unlike rhodopsin, most GPCR‟s have poor thermal 
stability and are subject to proteolysis due to the presence of their disordered loops that extend 
outside the membrane. Thermodynamic and proteolytic protein stability problems have been 
overcome by implementing mutations in the 1-AR receptor crystallization (Jaakola, Griffith et 
al. 2008), or by adding lipids during purification and crystallization in order to stabilize mobile 
regions of the protein and to create an environment more like the natural one.  Often cholesterol 
or other lipids were added during the rhodopsin crystallization and during the more recent 
crystallization of the beta-2-adrenergic with or without lysozyme T4L, and of the adenosine A2A 
coupled to T4L (Jaakola, Griffith et al. 2008).  In other instances, high salt concentration 
improved the thermal stability such as in the case of the adenosine A2A receptor crystallization.  
In order to enhance the proteolytic stability, at times truncation of the disordered regions has been 
employed, especially around the C-terminus, or of certain amino acids such serine, threonine 
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phosphorylation sites, or N-linked glycosilation sites since most post-translational modifications 
can be very heterogeneous (Cherezov, Rosenbaum et al. 2007; Hanson, Cherezov et al. 2008; 
Jaakola, Griffith et al. 2008).  Another method used towards achieving stability has been the 
complex formation with antibody Fab fragment as was performed in the case of the beta-2-
adrenergic and adenosine A2A crystallization (Rasmussen, Choi et al. 2007).  A common problem 
that had to be overcome is the fact that, in native tissues, most of these receptors (with the notable 
exception of rhodopsin) are expressed only at very low levels and therefore a suitable 
recombinant expression system usually has to be developed in order to generate membrane 
proteins that are folded properly. 
 Computer simulation and modeling methods have the potential to complement 
experimental investigations and make a great contribution to the studies of protein structure 
(Mulholland, Grant et al. 1993; Mulholland and Karplus 1996).  Using experimental structural 
information as a starting point, calculations can be performed in order to address questions that 
may be quite difficult or impossible to approach by experiment alone.  For example, often 
proteins are mutated in order to enhance their wild type stability (Park, Scheerer et al. 2008; 
Warne, Serrano-Vega et al. 2008) but computer simulations do not require such mutations. 
 Numerous computational molecular modeling methods are available, ranging from 
quantum chemistry to the interpretation of three-dimensional structure.  All techniques have 
certain strengths and weaknesses depending on the systems for which they were designed, so it is 
necessary to choose an appropriate method for the particular type of problem under investigation. 
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1.2 Molecular Modeling Method 
 The availability of powerful and relatively inexpensive computers has revolutionized 
science by allowing computer simulations to be used as one of the most versatile and capable 
tools.  Such computer calculations are now employed to create relevant models, to explain 
observed phenomena, to predict verifiable results, to explore possibilities, and to help develop 
answers as well as questions.  In the work presented here, the conformational space available to 
specific transmembrane helices (TMHs) of cannabinoid (CB) receptors was explored using 
Conformational Memories (CM) (Guarnieri and Wilson 1995; Guarnieri and Weinstein 1996), a 
Monte Carlo/simulated annealing (MC/SA) algorithm employing either the AMBER* (Weiner, 
Kollman et al. 1984) or  CHARMM  force field (Brooks, Bruccoleri et al. 1983).  CM is a 
stochastic and nonsystematic method meaning that the sampling is random in nature and uses 
statistical approaches which typically make it better suited for larger biomolecules (Chang, Guida 
et al. 2002; Ferguson and Raber 2002).  
The random nature of a Monte Carlo simulation assures that in the long run the 
simulation approaches equilibrium values, while an individual move has a real chance of moving 
the simulation away from equilibrium.  What follows is a discussion of the theory behind the 
molecular mechanics calculation, including a description of the conformational memories 
method, geometry optimization method, and the force field parameters.  The actual experimental 
set up is presented in the RESEARCH AND DESIGN METHODS section. 
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1.2.1 Conformational Memories (MC/SA algorithm)  
 In general, an annealing process consists of three stages: heating to a desired temperature, 
holding that temperature, and „annealing‟ or slow „cooling‟ plan, usually to either biological or 
room temperature.  Such an annealing process can be modeled successfully by computer 
simulation methods that use the Metropolis Monte Carlo algorithm proposed in 1953 (Metropolis, 
Rosenbluth et al. 1953).  In short, the Metropolis Monte Carlo Algorithm performs an 
“annealing”: at high temperatures, with 90% of all new conformations typically “accepted”.  An 
opposite trend starts to happen as the system is slowly cooled, until, at low temperatures, 90% of 
all new conformations are “rejected”.  The Metropolis Monte Carlo algorithm, also known as the 
Boltzmann-Weighted Monte Carlo algorithm is an acceptance criterion used to determine if a 
new conformation is added or not to the ensemble.  This criterion minimizes the possibility of 
unrealistic samples being considered.  The energy of each new conformation is evaluated and if it 
is less than the energy of the old conformation, then that conformation is kept.  If the energy is 
higher though, the Boltzmann probability of that conformation to occur at the current temperature 
is calculated.  This probability is a number between 0 and 1 and is compared to a random number 
between 0 and 1.  If the Boltzmann probability is higher than the random number, then the 
conformation of higher energy is kept.  The willingness to move uphill to a worse position gives 
simulated annealing the advantage of possibly escaping from local minima in hope of finding a 
deeper valley farther away, which prevents the simulation from becoming stuck in a valley that 
cannot be escaped by taking only downhill moves.  In that sense, temperature is the control 
parameter that represents the willingness to accept a bad move.  When the value of the 
temperature is large the willingness is great.  If the probability is lower than the random number, 
then the move is not accepted and the previous state is restored.  After a certain number of moves, 
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the temperature is decreased.  The Metropolis Monte Carlo simulation is then continued.  This 
process is repeated until the final temperature is reached.  Two cooling schedules are most 
frequently reported in the literature: linear or proportional.  In the experiments conducted here the 
proportional cooling schedule employed obeyed Tnew = 0.8995 x Told.  When no downhill (better) 
moves exist in the neighborhood, a local minimum has been reached.  This does not imply that it 
is the global minimum, however.  The algorithm terminates when some specified stopping 
criterion is met (for example when no improvement has been found for some number of moves).   
The factors that control how thoroughly the space of the system is searched are the size of each 
Monte Carlo step and the number N of the steps attempted.  Also, by using this acceptance 
probability criterion one can prove that the average of any property, such as energy, over the 
ensemble is equal to the Boltzmann average of this property as determined by the Boltzmann 
Distribution Law for a sufficiently large ensemble.  The Boltzmann average of a property is the 
expected value of this property at the given temperature (Metropolis, Rosenbluth et al. 1953; 
Kirkpatrick 1983). 
 Monte Carlo methods require very long samplings due to the fact that statistical methods 
require more steps for completeness.  In order to prove that the MC search has sampled long 
enough, the simulation should converge to the same ensemble regardless of the starting 
conformation, seed number (the “kick” or velocity given to move atom coordinates in a random 
direction), cooling schedule, or initial and final effective temperatures.  In practical terms, the 
number of steps has to be computationally reasonable, and often some dependence of these 
parameters on the final result does exist. 
 Thus, the most difficult aspect of the MC/SA is to determine how long to run the 
simulation at each temperature.  While the simulation attempts to reproduce the correct  
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Figure 1. A quick schematic of the Metropolis Monte Carlo algorithm. 
 
Boltzmann distribution at a given temperature, it only needs to run long enough to explore the 
regions of search space that should be reasonably populated.  This allows for a reduction in the 
number of MC steps at each temperature, but the balance between the maximum step size and the 
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number of Monte Carlo steps is often difficult to achieve, and depends very much on the 
characteristics of the search space or the energy landscape.  In general, temperature is used to 
scale differences in height of the landscape.  Raising the temperature flattens a rugged landscape 
by a greater willingness to accept worse moves.  Small irregularities on a smooth landscape are 
accentuated by lowering the temperature and accepting mostly improving moves (Metropolis, 
Rosenbluth et al. 1953). 
 In short, the Monte Carlo algorithm starts out at a temperature of 2070K and the energy 
of the current conformation evaluated.  The atomic coordinates are then moved in a random 
direction and the energy of the new conformation is compared to the original conformation.  If 
this energy is smaller the new conformation is kept and if it is higher, the Boltzman probability, 
(P = e 
–( 1- 0)/kT
 ) is compared to a random number, R, between 0 and 1 and the new conformation 
is kept only if P is greater than R.  These steps are repeated as many times as possible while the 
temperature follows a proportional cooling schedule according to Tnew= 0.9*Told for 19 
temperatures from Tstart= 2070 K to Tfinal = 310 K. 
 
1.2.2 Force Fields (AMBER*, CHARMM) 
 The first calculations based on force field methods were reported back in 1946 (Ponder 
and Case 2003) and were known as the Westheimer methods but they did not become more 
developed until the 1970s because of the increased availability of computers.  They are based on 
classical mechanics laws and use the ball-and-stick model for approximation of molecules.  The 
total energy of a molecule is assumed to be the sum of the individual energy components such as 
the intramolecular or internal, bonded terms (bond-stretching, angle-bending, torsional terms, 
impropers, Urey-Bradley) and intermolecular or external, nonbonded terms (van der Waals or 
electrostatic), as functions of conformations. 
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 The force fields used in molecular modeling have to reproduce structural properties.  
Force fields that have identical functional form may still have very different parameters. 
Empirical „molecular mechanics‟ potential functions have been developed that can model protein 
structure and dynamics effectively and efficiently.  Potential functions or force fields are 
mathematical functions that return energy as a function of conformation.  Many force fields used 
for modeling proteins and other biological macromolecules are sums of terms that correspond to 
bond, angle, torsion angle, van der Waals, and electrostatic interaction energies as functions of 
conformation.  Equation #1 below, illustrates the basic form of the force fields used for modeling 
proteins and other biological macromolecules. 
 
 
(eq. #1) 
 
 
 In the above expression kr and kθ are force constants in harmonic potentials for bonds and 
angles with equilibrium values r0 and 0 and actual values r and vely.  Cosine functions 
are usually used for the potential associated with torsion angle variation, with the multiplicity of 
the function n between 1 and 5 and the phase angle .  A Lennard-Jones (12, 6) potential is used 
for attractive dispersion (with coefficient Cij) and close range repulsion (with coefficient Aij) non-
bonded interactions, where rij is the distance between non-bonded atoms qi and qj.  The 
electrostatic interactions between non-bonded atoms depend on the atomic partial charges qi and 
qj.  To reduce the computational expense of a simulation, the number of non-bonded interactions 
can be limited by applying a cut-off beyond which no interactions are calculated. A cut-off range 
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is applied after which no van der Waals energies are calculated, this is normally between 8 and 12 
Å.  The cut-off is often used with a „switching function‟, which multiplies the van der Waals 
interactions and causes it to go smoothly to zero at the cut-off distance. 
 
Figure 2. Energy components illustration.   
 
 
Due to their low computational expense molecular mechanics force fields can handle long 
dynamics simulations of entire solvated proteins (Ponder and Case 2003).  In addition to the 
functional form of the potentials, force fields also define parameters for individual types of atoms, 
and distinct parameters for individual type of atoms in different environments such as oxygen in a 
carbonyl versus a hydroxyl.  Again, the parameters from one force field should not be used in 
combination with the parameters from a different force field, regardless of how closely related, 
because they may vary extensively. 
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1.2.3 Geometry Optimization 
It is difficult to locate the minimum on a potential energy surface analytically, due to its 
complex nature. Instead, numerical methods are used which gradually change the coordinates in 
the direction of decreasing energy until a minimum is reached.  Most minimization algorithms 
achieve this by using derivatives. It is useful to write the potential energy function of a system as 
a Taylor expansion: for a continuous differentiable function in one dimension at the point x, this 
is given in terms of the function and its derivatives at the point x0. 
 
(eq. #2) 
 
 For a non-linear molecule, the energy is a function of 3N Cartesian coordinates (or 3N - 6 
internal coordinates), and so the equivalent multidimensional expression from equation # 2 
applies.  In this multidimensional function x is replaced by the vector x and matrices are used for 
the derivatives.  
 There are many methods that have been developed for molecular energy minimization 
and these are classified according to the highest-order derivative they use. The first order methods 
use only the gradient of the function, e.g. steepest descent (Wiberg 2002) and the Powell 
conjugate gradient (Fletcher and Powell 1963), whereas second order methods use both the first 
and second derivatives, e.g. adopted basis Newton-Raphson (Boyd 1968).  In this work, steepest 
descent minimizations have been used.  
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1.2.3.a Steepest Descent 
 Steepest descent is a simple minimization method where each step involves moving in a 
negative direction to the gradient (Wiberg 2002).  At every iteration, if the step decreases the 
energy, the size of the next step is increased, whereas if the energy is increased, the step size is 
decreased. Steepest descent minimization is widely used in studies of biomolecules. Its main 
advantage is that the energy can be lowered very quickly. The disadvantage is that as the 
minimum is approached, the rate of convergence slows down and the minimum may never be 
reached. In practice, steepest descent is used at the beginning of minimization protocols, to 
relieve bad non-bonded contacts or reduce strain in a system.  
 
1.2.4 Dielectric Constant 
 The dielectric constant basically dampens the charge-charge interactions and is a function 
of the solvent.  The greater the value, the less electrostatic interactions exist between the atom 
pair.  For example, in a vacuum the dielectric constant is 1.0, in water ~80, in lipid 3-5.  The 
charges can be used from a file or from a force field (for example, in AMBER, a popular way to 
generate an electrostatic potential is from high level ab initio calculations and then fit the optimal 
point charge distribution on the atoms via least-squares methods).   
 
1.3 Historical Overview of the Cannabinoid System 
 Cannabis sativa, the plant from which 
9
-tetrahydrocannabinol (THC) is derived, is still 
one of the most abused drugs in the world.  It wasn‟t until the 1960‟s that the structure of the 
principal psychoactive compound present in the plant (
 9
-THC) was elucidated and later some of 
the specific effects of this compound could only be explained if they were due to action on 
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receptors or enzymes.  In 1988, Allyn Howlett and her group (Devane, Dysarz et al. 1988) 
showed that there is a cannabinoid receptor (CB1) in the brain.  Subsequently, since nature would 
not have designed receptors just for the sole purpose of binding plant-derived compounds, 
researchers looked for endogenous cannabinoid ligands.  In the 1990‟s,  anandamide (AEA) 
(Devane, Hanus et al. 1992) and 2-arachidonoyl glycerol (2-AG) (Mechoulam, Ben-Shabat et al. 
1995) were found as the natural ligands produced by the body for interaction with cannabinoid 
receptors.  A second cannabinoid (CB2) receptor was also identified in the spleen (Munro, 
Thomas et al. 1993).  Additionally, endogenous cannabinoids are found present in mammalian 
cells early in their development, as well as in some of the simplest multicellular organisms.  This 
suggests a basic and vital role that the cannabinoid system plays in the biology of these 
organisms, including humans.   
 In the last couple of decades there has been an increased interest in the potential 
medicinal properties of the cannabinoids and their possible role in modulating neurobiological 
activities.  This is due to the fact that the endocannabinoid system appears to play a role in a large 
number of physiological processes, including nervous functions, emotions, movement, learning, 
memory, pain, appetite, blood and intraocular pressure, regulation of cell development and 
growth, and immune and reproductive functions (Goutopoulos and Makriyannis 2002).  Most of 
these effects have been attributed to action at either the cannabinoid CB1 or CB2 receptors that 
are found in most biological systems.  However, some cannabinoid effects are not due to action at 
either CB1 or CB2.  There is quite enough evidence that suggests that some of these cannabinoid 
effects may be due to the involvement of the endogenous ligand of vanilloid type (TRPV1) 
receptor and at least one other G protein coupled receptor (GPCR), defined pharmacologically as 
a cannabinoid receptor only recently: GPR55 (Begg, Pacher et al. 2005).  A fairly wide range of 
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cannabinoid ligands have been reported to display affinity/ efficacy (Brown and Wise 2001; 
Brown 2007) for GPR55.   
 
1.3.1 G-protein Coupled Receptors (GPCRs) Class A 
1.3.1.a GPCRs General Structure 
G protein-coupled receptors (GPCRs) represent the largest super-family of the integral 
transmembrane proteins class.  GPCRs are important in activating cellular signal transduction 
mechanisms; hence they are significant in many vital physiological events.  Not surprisingly, 
GPCRs are major targets for drug development.  Because integral proteins are inherently very 
difficult to crystallize, until 2007 only the Class A GPCR rhodopsin was crystallized (Palczewski, 
Kumasaka et al. 2000; Teller, Okada et al. 2001; Okada 2002; Li, Edwards et al. 2004; Okada, 
Sugihara et al. 2004; Nakamichi and Okada 2006; Nakamichi and Okada 2006; Salom, Lodowski 
et al. 2006).  From these Rhodopsin crystal structures, the general topology of G-protein coupled 
receptors in general, began to be shaped (see Figure 3).  GPCR‟s have an extracellular N 
terminus, seven transmembrane (TM) alpha helices connected by loops that extend intracellularly 
and extracellularly and an intracellular C terminus that begins with a short helical segment that 
runs parallel to the membrane (Helix 8).  The availability of the newer crystal structures of the 2-
adrenergic ( 2-AR) (Cherezov, Rosenbaum et al. 2007; Rasmussen, Choi et al. 2007), 1-
adrenergic ( 1-AR) (Serrano-Vega, Magnani et al. 2008), opsin (Park, Scheerer et al. 2008; 
Scheerer, Park et al. 2008), and adenosine A2A (Jaakola, Griffith et al. 2008), along with the 
availability of biophysical data on the conformational changes that occur when these receptors are 
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activated have greatly aided understanding of structure-function relationships of other Class A 
GPCRs.  
 
Figure 3. Typical GPCR topology. 
 
 
 
 
 
 
 
 In Figure 3 A the GPCR transmembrane helix bundle is seen from the lipid side in which 
the N-terminus is at the top of the figure and the C-terminus at the bottom of the figure.  Figure 3 
B shows the bundle from the extracellular view. 
 
1.3.1.b GPCRs Activation 
Most of the in depth information about the conformational changes that may occur when 
GPCRs become activated has been generated from biophysical studies on these changes in Rho or 
the 2-AR.  Much evidence has emerged from these studies that suggest activation in these 
receptors is accompanied by a few movements of key structural domain contacts.  These key 
motifs may be identical in some receptors, but also mimicked by alternate similar domains that 
form or break and thus promote activation in other receptors (Ballesteros, Shi et al. 2001). 
 The conventional model of agonist activation of the GPCRs involves two states, a ground 
or inactive (R) state and an active (R*) state, that are in equilibrium with each other.  From 
studies performed on Rho and the 2-AR, activation in these receptors is thought to be associated 
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with the movement of TMH3 and TMH6.  P6.50 in TMH6 is part of the highly conserved CWXP 
motif that may act as a flexible hinge that allows TMH6 to straighten during activation, moving 
its intracellular end away from the core of the receptor and upwards towards lipid (Jensen, 
Guarnieri et al. 2001).   In Figure 5, the TMH6 sequence of Rho and CB receptors is illustrated.  
From here it can be seen that in CB receptors, the CWXP amino acid motif is CWGP for CB1, 
CWFP for CB, and SFLP for GPR55, while in Rho, this motif is CWVP.  In the 1 2-AR, 1-AR, 
and A2A this motif is CWLP.  From the 2.80 Å Rho crystal structure (Palczewski, Kumasaka et al. 
2000), residue W265 (number of the amino acid in the receptor sequence) undergoes a change in 
its chi1 torsion angle from g+ (-60°) to trans (180°) when Rho is activated (Lin and Sakmar 
1996).  This amino acid is also designated the notation W6.48 according to the The Ballesteros-
Weinstein numbering system (Ballesteros and Weinstein 1995).  This notation and the absolute 
sequence numbers for the TMH6 in a few GPCR‟s are described bellow and illustrated in Figure 
4 and 5, respectively. 
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CHAPTER II 
RESEARCH AND DESIGN METHODS 
2.1 Amino Acid Numbering System 
 The amino acid numbering scheme proposed by Ballesteros and Weinstein is used here 
when referring to receptor residues (Ballesteros and Weinstein 1995).  In this numbering system, 
the most highly conserved residue in each transmembrane helix (TMH) is assigned a locant of 
.50.  This number is preceded by the TMH number and is followed in parentheses by the 
sequence number.  All other residues in a TMH are numbered relative to this residue.  In this 
numbering system, for example, the most highly conserved residue in TMH2 of the hGPR55 
receptor is D2.50(70).  The residue that immediately precedes it is F2.49(69).  Residues in the 
intracellular extension of TMH7 (Hx8) are numbered as if they are part of TMH7 following the 
literature precedent set by Prioleau and co-workers (Prioleau, Visiers et al. 2002). Sequence 
numbers used are human GPR55 or CB2 sequence numbers unless otherwise noted. 
 
2.2 Definition of Rotameric State of Chi1( 1) Angle 
 When referring to 1 torsion angles or the rotameric state of a residue the nomenclature 
employed here is the one described by Shi et al(Shi, Liapakis et al. 2002).  When the heavy atom 
at the  position (atom number 1 in Figure 7) is opposite to the backbone nitrogen when viewed 
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from the carbon (atom number 2) to the carbon (atom number 3), the 1 is defined to be 
trans.  Similarly viewed, when the same heavy atom (1) is opposite to the backbone carbon is 
defined to be gauche minus (g-), while when the same heavy atom  is opposite to the 
hydrogen is defined to be gauche plus (g+).  Therefore, the side chain conformations discussed 
here are categorized g- (0° < 1 < 120°), trans (120° < 1 < 240°), g+ (240° < 1< 360°) (Singh, 
Hurst et al. 2002).  
 
Figure 4. Illustration of the W6.48 g plus and trans conformations. 
 
 
 In Figure 4, the labels 1, 2, 3, and 4 represent the atoms that make up the dihedral angle. 
In trans (yellow 1, 2, 3, 4 atom labels) conformation the heavy atom 1 is opposite from the 
backbone N (atom number 4), while in g plus (green 1, 2, 3, 4 atom labels) conformation the 
heavy atom 1 is opposite from the backbone carbonyl carbon (atom number 4).  
In the dark (inactive) state of Rho, the -ionone ring of 11-cis-retinal is close to 
W6.48(265) of the TMH6 CWXP motif and helps constrain it in a 1 = g+ conformation 
(Palczewski, Kumasaka et al. 2000; Okada 2002; Li, Edwards et al. 2004).  In the light activated 
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state, the retinal  -ionone ring moves away from TMH6 and toward TMH4 where it resides close 
to A4.58(169) (Borhan, Souto et al. 2000).  The beginning of this movement is clear in the 
lumirhodopsin structure (Nakamichi and Okada 2006).  This movement releases the constraint on 
W6.48(265), permitting this residue to undergo a conformational change.  Both cryo-electron 
microscopy and NMR studies indicate that W6.48 changes position, as well as interaction 
partners during receptor activation (Schwartz and Rosenkilde 1996).  This suggests that the 
conformation of W6.48(265) when Rho is in its inactive/ground state (R; 1  = g+) changes 
during activation (i.e., W6.48(265)  1  g+ to trans ) (Shi, Liapakis et al. 2002). Toggle switch 
mechanisms for GPCR activation involving the W6.48 1 g+ to trans transition have been 
proposed and tested for other GPCRs (Schwartz, Frimurer et al. 2006), including the 1-AR (Shi, 
Liapakis et al. 2002) and the cannabinoid CB1 receptor (Singh, Hurst et al. 2002; McAllister, 
Hurst et al. 2004).  Each of these mechanisms involves aromatic stacking interactions between 
W6.48 and other “toggle switch” residues (Yao, Parnot et al. 2006).  With these reported findings 
in mind, the hypothesis in Specific Aim 1 was formulated and the Conformational Memories 
method was first tested using CB2 TMH6 as a case study for which experimental data is available 
for validation.  In contrast to the more studied GPCRs, CB1 and CB2 have been shown to have a 
high level of ligand-independent activation, whereas rhodopsin is quite the opposite, as it exhibits 
an exquisite lack of constitutive activity.  No data in this respect is available yet about GPR55.  In 
this aim, it is hypothesized that a conformational change in 1 of W6.48 is also part of the 
activation process of CB2 receptor and that the lack of an aromatic residue at the position 6.44 
may contribute to the increased constitutive activity of CB2 (relative to Rho) as was shown for 
CB1(Singh, Hurst et al. 2002).  By looking at the sequence presented in Figure 5 it can be seen 
that Rho has aromatic residues at positions i-4 and i+3 from W6.48 (F6.44 and Y6.51, 
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respectively).  A similar situation is present in the cationic neurotransmitter receptors, such as 
alpha-1B- and beta-2-adrenergic receptors, where W6.48 is flanked by F6.52 and F6.51 above 
and F6.44 below.  In contrast to Rho and 2-AR, in CB1 and CB2 these residues are Leu and/or 
Val (L/L6.44 and L/V6.51, respectively; Figure 5).  In GPR55 these residues are F6.44 (i-4) and 
V6.51 (i+3).  It has been reported that in the inactive state of Rho, F6.44(261) ( 1 trans) interacts 
with W6.48 (265) ( 1 g+).  Han and coworkers reported that a F6.44 (261)V mutation in Rho led 
to measurable constitutive activity (Han, Smith et al. 1998).  Chen and coworkers reported that a 
F6.44L mutation in the alpha-1B -adrenergic receptor and a F6.44L mutation in the 2-AR 
receptor led to constitutively activated receptors, as well (Chen, Lin et al. 2001; Chen, Lin et al. 
2002).  
 
Figure 5. Alignment of the CB1, CB2, Rho, and GPR55 sequences in the TMH6 region.  
 
  
 In the above illustration of the alignment the last 5 residues of the helix are not shown. 
The Ballesteros-Weinstein numbers
 
 (Ballesteros and Weinstein 1995) and absolute sequence 
numbers for each are listed below the sequence comparison. 
 In Specific Aim 2, the refinement of the initial inactive state (R) of the GPR55 receptor 
model built in the Reggio‟s lab (Hurst, Barnett-Norris et al. 2006) was continued by exploring the 
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conformational space available to four flexible helices.  The initial model was constructed from a 
template of the 2.65 Å crystal structure of bovine Rho (1GZM) (Li, Edwards et al. 2004) and with 
the aid of the MODELLER program (Fiser, Do et al. 2000; Marti-Renom, Stuart et al. 2000).  
 
Figure 6. GPR55 topology. 
 
 
 Figures 6 and 7 show representative views of the GPR55 model with some of the 
important features of its binding pocket.  Dr Reggio‟s research group and collaborators have 
cloned and expressed the GPR55 receptor and preliminary studies confirm that multiple 
cannabinoid compounds activate this receptor.  
 Like CB1 and CB2, GPR55 has the following conserved residues among the Class A G-
protein coupled receptors: N1.50, D2.50, W4.50 and P6.50.  GPR55 also has P5.50 conserved, 
while CB1 and CB2 do not.  The other conserved key motif of GPCRs found in GPR55 is the 
TMH3 DRY motif, with the conserved aromatic residue being F instead of Y in GPR55.  Also, 
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the highly conserved TMH6 CWXP motif aligns with SFLP corresponding motif in the alignment 
of the TMH6 in GPR55 with other GPCRs.  These residues parallel CWXP since S is a 
conservative substitution for C and since F is a conservative substitution for W.  Another 
important similarity with Rho, but not to the classical cannabinoids, is the presence of F7.60 in 
the intracellular extension of TMH7, Hx8.  The greatest divergence from Rho and the other 
cannabinoid receptors lies in the fact that the highly conserved NPXXY motif is replaced with 
DVFCY in GPR55.  
 Figure 7 illustrates key features of the preliminary GPR55 model built in the Reggio lab: 
charged residues in the binding site crevice of GPR55 are illustrated in yellow.  In this model, the 
aromatic residues Y3.32, F3.33, Y3.37, H4.64, F5.39, F5.47, F6.48, H6.52, F6.55 and F6.59, 
shown in white, were identified as potential aromatic microdomains available for ligand 
interaction.  Similar findings were reported to exist in CB1 (McAllister, Rizvi et al. 2003) and 
CB2 (Zhang, Hurst et al. 2005).  In green, the residues that could H-bond are highlighted. Reggio 
has proposed that beta-branching residues (V6.43/I6.46) that face lipid on TMH6 may be a motif 
that helps pull endocannabinoids into the binding site of CB1 and CB2 (Barnett-Norris, Hurst et 
al. 2002) and recent mutation data supports this hypothesis (Reggio, Nebane et al. 2005).  GPR55 
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Figure 7. GPR55 binding pocket. 
 
possesses on the lipid face of TMH6: V6.43/V6.46.  These residues are displayed in blue in 
Figure 7. 
 
2.3 Structure Creation and Minimization 
 Each helix of interest was built using Macromodel (Schrödinger Inc., Portland, OR, 
USA). The helix was first minimized using the AMBER* force field in Macromodel (Mohamadi, 
Richards et al. 1990).  Each helix was then capped with acetamide at the N terminus and with N-
methyl amide at the C terminus.  The charges on all charged residues were reduced to one-third of 
their values to prevent artifacts during the CM runs.  These artifacts occur because the runs were 
performed in vacuum and the individual helices studied were isolated from the naturally 
surrounding lipids and the rest of the receptor.  When present, charged residues, which would 
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otherwise interact with surrounding native partners, in the system used, if left fully charged these 
residues would find each other and distort the structure of the helix. 
 
2.4 Conformational Memories (CM) Method  
The CM method (Guarnieri and Weinstein 1996) employs multiple Monte Carlo/ 
simulated annealing random walks and the united atom force fields AMBER* or CHARMM 
(PARAM19 force field).  The runs were performed in vacuum and using a distance dependent 
dielectric.  CM has been shown to converge in a very practical number of steps, and to be capable 
of overcoming energy barriers efficiently (Singh, Hurst et al. 2002).  A new version of CM 
generated in the Reggio lab uses the CHARMM force field (Whitnell, Hurst et al. 2007).  Force 
field methods have a long history (1946) and they rest on the fundamental concept of the ball and 
spring model and are used to approximate a molecule.  Furthermore, it is assumed that the total 
energy of the molecule is a summation of the individual energy components such as bond 
stretching, angle bending, nonbonded interactions, torsion interactions, cross energy terms.  The 
CM method has two phases: the exploratory phase and the biased phase. 
 
2.4.1 Exploratory Phase 
In the exploratory phase, a random walk is used to identify the region of conformational 
space that is populated for each torsion angle studied.  Starting at a temperature of 2070 K or 
3000 K, 50,000 steps are applied to the rotateable bonds with cooling in 18 steps to 310 K.  Trial 
conformations are generated at each temperature by randomly picking 2 or 3 torsion angles from 
the set of torsion angles for each helix, and changing each angle by a random value within the 
range set in the calculation.  After each step, the generated trial conformation is either accepted or 
rejected using the Metropolis criterion.  Accepted conformations are used to map the 
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conformational space of each helix by creating „memories‟ of values for each torsion angle that 
are accepted.  The CM runs are performed in parallel, with either ten sets of 10 runs or four sets 
of 25 runs.  Each set of runs uses a different random number seed.  The output from these runs is 
combined to generate the „memories‟ used for the biased annealing phase. 
 
2.4.2 Biased Phase 
In the second CM phase, only torsion angle moves that would keep the angle in the 
„populated conformational space‟ mapped above are attempted.  The Biased Annealing phase 
begins at a temperature of 722 K with cooling to 310 K in 8 steps.  Runs are performed in 
parallel, with either ten sets of 10 or four sets of 25 runs, each using the combined „memories‟ 
from the first phase of the calculation, but initiated with a different random number seed for the 
biased annealing phase of the calculation. Finally, 100 structures are output at 310 K.  
Conformational families of the flexible molecule/helix at 310 K are characterized from the results 
of the biased sampling technique by clustering conformations according to a pairwise root mean 
square deviation criterion (Mohamadi, Richards et al. 1990). 
 In the CM protocol used in this study, the phi ( ) and psi ( ) angles of the region of the 
helix backbone thought to be the flexible hinge region were varied by ± 50 , while the rest of the 
helix backbone was only varied by ±10 .  The chi ( ) angles were allowed to vary ±180  unless 
otherwise specified.  Reggio‟s group has performed the control experiment in which all backbone 
 and  torsion angles were allowed to vary ±50 .  In this experiment, they found that lower 
acceptance rates were obtained, but the same results for helix conformation were observed in the 
output structures, such that extreme variations from alpha helicity were seen only in regions 
containing helix distorting residues/motifs, such as the motifs containing prolines, serines, or 
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double glycines.  This occurs because when CM tries a large  and  change in regions of the 
helix that do not contain helix distorting residues or motifs, the resultant high-energy helix 
conformations are not accepted by the Metropolis criterion. 
 
2.5 Analysis 
The proline kink (bend, B), wobble (W) and face shift (FS) angles for each set of 100 
helices were calculated using the Prokink program (Mohamadi, Richards et al. 1990) available 
within the Simulaid package (M. Mezei, can be searched at the following web address: 
http://fulcrum.physbio.mssm.edu/~mezei/simulaid/).  In this method the bend, wobble and face 
shift angles are as defined in Figure 7.  The helix is described as being composed of two parts: the 
pre-proline helix (from the N-terminus to the proline residue) and the post-proline helix (from the 
C-terminus to the proline residue).  The angle between the two parts is the bend angle.  The 
wobble angle is defined as the angle between the projection of the post-proline helix to the yz 
plane and the C alpha atom of the proline and origin, as the C alpha is positioned on the positive y 
axis such that the center of the pre-proline helix is located on the positive x axis, as shown in 
Figure 7.  The face shift angle is related to the bend and wobble angles and measures the twist 
that occurs in the helix due to the proline kink.  If one looks from a side, in an ideal alpha helix 
the amino acids i-4 and i-3 from the proline, are located on the same side of the helix.  In a bent 
helix, these residues are shifted in a bent helix, such that they are on different sides (see Figure 8). 
 In Specific Aim 1, the criterion that W6.48 undergoes a shift in its  (g+ to trans) during 
activation was used (Lin and Sakmar 1996).  The W6.48  rotamer states of the resultant helices 
were assessed according to the number of helices of each TMH6 (WT CB2 for wild type CB2, 
L6.44F mutant CB2), which exist in an inactive (W6.48 g+ ) vs. an active (W6.48 trans ) 
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W6.48 rotamer state.  The Prokink program was applied around P6.50 of TMH6 in CB2 with 
the flexible region varied from I6.46 to P6.50 (ICWFP).  In Specific Aim 2, the Prokink Analysis 
was performed similarly on the last residue of the flexible region varied: for TMH2, the flexible 
region was from V2.54 to P2.58 (VLSLP), for TMH5 flexible regions (one at a time) were: K5.37 
to P5.41 (KVFFP), G5.46 to P5.50 (GFLLP), M5.51 to G5.55 (MGIMG), for TMH6 the flexible 
region was V6.46 to P6.50 (VSFLP), and for TMH7 the flexible region was C7.46 to V7.50 
(CCLDV). 
 
Figure 8. Illustration of the structural parameters of the proline bend angle, wobble angle and face shift. 
 
 
 For the exploration of the influence that bracketing aromatics have upon 6.48 
conformation in the cannabinoid receptors, the previously developed protocol for TMH6 studies 
was used (Singh, Hurst et al. 2002). We looked for the pattern of aromatic residue  torsion 
angles when the  of 6.48 is in g+ (inactive state conformation) vs. when the  of 6.48 is in 
trans (active state conformation) (see section 1.4.2 Activation of GPCRs) to see if there are 
correlations between the aromatic torsion angles that would suggest a uniform movement of 
these residues as 6.48 moves from a g+ to a trans .  Such a correlation would suggest that 
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these flanking aromatics act as a “toggle switch” or may explain the degree of constitutive 
activity. 
 
2.6 Experimental Procedures (Collaborator) 
The following experimental procedures are only briefly described and referenced to the 
work done in Dr Zhao-Hui Song‟s lab at University of Louisville School of Medicine. 
 
2.6.1 Ligand Binding Assay 
Ligand binding assays were performed as described previously (Zhang, Hurst et al. 2005) 
with slight modifications. For membrane preparations, cells were washed twice with cold PBS 
(8.1mM NaH2PO4, 1.5mM KH2PO4, 138mM NaCl, 2.7mM KCl, pH 7.2) and scraped off the 
tissue culture plates. Subsequently, the cells were homogenized in binding buffer (50 mM Tris– 
HCl, 5 mM MgCl2, 2.5 mM EDTA, pH 7.4) with a Polytron homogenizer. After the homogenate 
was centrifuged at 34,000 g for 30 min at 4°C, the pellet was resuspended in binding buffer and 
10 stored at -80°C until use. Protein concentrations were determined with Bradford method using 
Bio-Rad protein assay reagent (Bio-Rad, CA). Bovine serum albumin (BSA) was used as the 
standard. For binding assays, cannabinoid ligand dilutions were made in binding buffer 
containing 0.5 mg/ml of BSA and then added to the assay tubes. [3H]-CP55940 was used as a 
labeled ligand for competition binding assays. Nonspecific binding was determined in the 
presence of 1 M unlabeled CP55940. Binding assays were performed in 0.5 ml of binding buffer 
containing 0.5 mg/ml of BSA for 60 min at 30°C. Free and bound radioligands were separated by 
rapid filtration through polyethylenimine-treated GF/B filters (Whatman International) with a 
Brandel cell harvester (Gaithersburg, MD). The filters were washed three times with 3 ml of cold 
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wash buffer (50 mM Tris–HCl, pH 7.4, containing 1 mg/ml of BSA). The bound [3H]-CP55940 
was determined by liquid scintillation counting after overnight equilibration in 5 ml of 
scintillation fluid (MP Biomedicals, Irvine, CA). The assays were performed in duplicate, and the 
results represent the combined data from at least three independent experiments.  
 
2.6.2 Assay of cAMP Accumulation 
cAMP accumulation assays were performed using a method described previously by 
(Song and Bonner 1996).  Briefly, cells were grown to confluence, washed twice in PBS 
containing 0.5 mM EDTA, and then collected in DMEM containing 0.2% (w/v) fatty acid free 
BSA. Subsequently, the cells were centrifuged at 500×g for 5 min at 25°C, and resuspended in 10 
ml of DMEM containing 0.2% (w/v) fatty acid free BSA. After counting the cell number, the cell 
suspension was diluted to 2×106 cells per milliliter. To prevent the hydrolysis of cAMP, the cells 
were incubated with 0.2 mM RO20-1724, a phosphodiesterase inhibitor, for 10 min before 
stimulation. The stimulation was initiated by adding aliquots of cells to silanized test tubes 
containing forskolin with or without cannabinoids and incubated for 10 min at 37°C. The final 11 
assay volume was 250μl with 4×105 cells per tube. For ligand-induced inhibition of cAMP 
accumulation assays, we used a final forskolin concentration of 1μM and a series of 
concentrations of CP55940. For constitutive activity assays, cells were stimulated by different 
concentrations of forskolin (0.1-10μM) with or without 1 μM CB2 specific inverse agonist 
SR144528. The reaction was stopped with the addition of 250μl of stop solution (0.1 M HCl, 
0.1mM CaCl2), after which 50μl was removed for cAMP radioimmunoassay, using a kit from 
PerkinElmer (Boston, MA). 
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CHAPTER III 
RESULTS AND DISCUSSION 
3.1 Specific Aim 1 – Computational Method Optimization 
3.1.1 Computational Results 
The force field employed (AMBER* or CHARMM) and the helix starting structure were 
compared while exploring the conformational mobility of the peptide.  The method used was the 
biased Monte Carlo/simulated annealing Conformational Memories (CM), which is described in 
the Research and Design Methods Section.  TMH6 is important in the activation of CB2, as well 
as in other GPCR‟s.  For this reason, the conformations that are possible could give insight in the 
ligand-receptor and ligand-independent activation of the receptor.  Relevant experimental data is 
also available for validation from Zhao-Hui Song‟s lab (R. Zhang et al., manuscript submitted 
2010), which is presented in the Experimental Results section (see Table 2).  
Two different starting conformations were used.  In Starting Conformation I, the human 
WT CB2 TMH6 and an L6.44F mutant were built using Macromodel (Schrödinger Inc., Portland, 
OR, USA) and minimized using the AMBER* force field in Macromodel (Mohamadi, Richards 
et al. 1990).  In Starting Conformation II, TMH6 from the rhodopsin crystal structure (1GZM) 
was mutated to the corresponding CB2 residues using Maestro and the side chains (but not the 
helix backbone atoms) were minimized using the AMBER* force field in Macromodel 
(Mohamadi, Richards et al. 1990).   
 In this aim, it was hypothesized that a change in the conformation of W6.48 is part of the 
activation process of CB2 receptor and that the lack of an aromatic residue at the position 6.44 
 
 
32 
could increase constitutive activity of this receptor like it was shown for CB1(Singh, Hurst et al. 
2002).  By looking at the sequence presented in Figure 4 (Introduction Section), the Rho 
sequence has aromatic residues at positions i-4 and i+3 from W6.48 (F6.44 and Y6.51, 
respectively).  A similar situation is present in the cationic neurotransmitter receptors, such as the 
α-1B- and beta-2-adrenergic receptors, where W6.48 is flanked by F6.52 and F6.51 above and 
F6.44 below.  Unlike Rho and -AR, the cannabinoid receptors have Leu and/or Val (L/L6.44 
and L/V6.51, respectively; Figure 3).  It has been reported that in the inactive state of Rho, 
F6.44(261) ( trans) interacts with W6.48 (265) ( g+), while Han and coworkers reported that a 
F6.44(261)V mutation in Rho led to measurable constitutive activity (Han, Smith et al. 1998).  
Similarly, Chen and coworkers reported that a F6.44L mutation in the α-1B-AR and a F6.44L 
mutation in the -AR receptor led to constitutively activated receptors, as well (Chen, Lin et al. 
2001; Chen, Lin et al. 2002).   For this reason the L6.44F mutant was studied here with the F6.44 
constrained in either a g plus or trans conformation (see Table 1). 
In Table 1, the results of the rotamer distribution for the W6.48  for the WT runs show 
that in Starting Conformation I there is a preference for the W6.48 = g plus (inactive), while in 
the Starting Conformation II the populations of g plus  or trans are equal.  In the case of the 
L6.44F mutant runs, regardless of the starting conformation of the original TMH6, 
Conformational Memories calculations suggest that over 95% of the population of the output 
helices have W6.48 in the inactive state conformation ( = g plus) when F6.44 adopted a 
conformation of = g plus.  The trans population for W6.48 is preferred in over 60% of the 
helices when F6.44 has a conformation of = trans.   
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Table 1. Summary of CB2 WT and L6.44F mutant runs: Percentage Rotamer Populations ( ) of W6.48 
and corresponding Prokink Data.  
CB2 
TMH6 
Constraine
d Residue 
(F6.44 in 
mutants) 
W6.48 1 
conformation in 
the output 
structures 
Bend (B) Wobble 
(W) 
Face Shift 
(FS) 
Starting      
Structure 
 I or II 
1 
# of 
Structures 1
 average range average average 
WT-I N/A 13 t
a
 23.93 [18.3 – 32.5] 140.62 -18.95 
   87 g +
b
 20.70 [12.9 – 32.6] 123.84 -18.39 
L6.44F-I 100 g+ 3 t 22.92 [17.9 -28.6] 116.44 -35.05 
   97 g + 22.07 [12.6 – 37.2] 127.55 -20.35 
L6.44F-I 100 trans 63 t 21.63 [11.8 – 37.6] 118.44 -20.13 
   37 g + 19.57 [11.5 – 26.5] 120.68 -26.05 
WT-II N/A 48 t 28.37 [11.0 – 47.5] -72.70 95.46 
   52 g + 25.90 [5.3 -43.7] -80.41 94.06 
L6.44F-II 100 g+ 4 t 25.88 [7.0 – 35.9] -63.20 92.86 
   96 g + 27.56 [9.8 – 47.2] -78.60 93.49 
L6.44F-II 100 trans 66 t 28.34 [13.8 - 48.8] -81.75 95.87 
   34 g + 27.33 [11.2 – 47.5] -73.12 96.83 
a
 trans and 
b 
g plus 
The results of Prokink Analysis for WT CB2 TMH6 Starting Conformation I are also 
presented in Table 1.  The first three entries in the table represent the WT and L6.44F runs of the 
TMH6 helix built in Starting Conformation I, while the last three entries represent the WT and 
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L6.44F runs of the TMH6 helix built in Starting Conformation II.  The force field used in these 
calculations was AMBER*.  The bend angle (B) is the angle between the two parts of the helix 
that are on each side of the proline residue.  For the TMH6 structures in which the W6.48 is 
trans this angle was found to be slightly larger than for the helices in which the W6.48 is g plus 
(Table 1, and Figures 8, 9 and 10), however, because the ranges overlap between the two 
populations, this trend is not statistically significant.  This trend in bend angle is the opposite of 
that seen in CB1(Singh, Hurst et al. 2002).  The bend appears biased by the starting conformation, 
such that whether wild type or mutant, the helices from Starting Structure II with W6.48 in g+ or 
in trans, show a slight trend towards being more bent than the corresponding helices from the 
Starting Structure I runs. 
Figure 9 illustrates bend and wobble angle ranges for CB2 receptor wild type.  Helices 
from the Starting Structure II are more bent than those from Starting Structure I.  Helices that 
have W6.48 = trans are slightly more bent on average than those with = g+.  Helices from 
Starting Structure I have positive wobble angles and negative face shift angles (over-wound), 
while helices from Starting Structure II (darker colors) have negative wobble angles and positive 
face shift angles (under-wound).  In Figure 9A Starting Structure I is represented in light colors 
(light green for the W6.48 = g+ helices and yellow for the W6.48 = trans helices). In Figure 
9B Starting Structure II is illustrated in dark colors (dark green for the W6.48 = g+ helices and 
orange for the W6.48 = trans helices).  In Figure 9C Starting Structure I and II are overlaid.  
The output helices are superimposed intracellularly (first 10 residues).  The views are from the 
extracellular side (bottom of each figure) and from the transmembrane side (right of each figure). 
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Figure 9. Bend and wobble angle ranges for the wild type CB2 receptor.  
 
 As mentioned in the Methods section, the wobble angle (W) is the angle that describes 
the orientation of the post-proline helix (the part from the proline residue to the C-terminus) with 
respect to the pre-proline helix (the part from the proline residue to the N-terminus) in 3D.  From 
Table 1 it can be seen that the wobble angle of the output helices from Starting Conformation I is 
significantly different from the Starting Conformation II in both wild type and mutant helices 
(Figures 9 and 10). 
Figure 10 shows a comparison between Starting Structure I and II wobble angle ranges 
for wild type (WT) and mutant (MT) output helices.  The helices are shown as they are 
superimposed on the extracellular backbone composed of the last 10 residues (post proline).  Both 
intracellular and side views are illustrated.  In the left side of the figure (A) the helices in which 
W6.48 conformation was g+ are shown, while on the right hand side of the figure (B) the W6.48 
trans helices are shown.  Figure 10 shows that the wobble angles are significantly different 
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depending on what starting structure is used: I versus II, while the wobble angles are not 
significantly different between helices within the same starting structure. 
 
Figure 10. Comparison between Starting Structure I and II wobble angle ranges for wild type (WT) and 
mutant (MT) output helices. 
 
The face shift angle is related to the bend and wobble angles, hence it is also very 
different between the two starting conformations, but it still represents a useful indicator because 
it measures the distortion that causes a twist in the helix such that residues that were on the same 
side of the helix will be on different sides because of the bend caused by the proline.  The atoms 
involved in this distortion are i-4 and i-3 from the proline (see Figure 8 in Methods Section).  A 
negative shift, as is observed in the output helices from the Starting Structure I, imply that the 
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helix is over-wound as a result of the proline kink.  In contrast, the helices from Starting Structure 
II are under-wound.  
 
Figure 11. Comparison between Starting Structure I and II wobble angle ranges for wild type (WT) and 
mutant (MT) output helices.  
 
 To the left in Figure 11 A, there is an illustration of output helices from all the runs from 
Starting Structure I (WT, MT with F6.44 constrained gplus and trans) superimposed on the 
extracellular last 10 residues and colored in red and yellow depending on the W6.48 
conformation and the output helices from all the runs from starting structure II superimposed on 
the extracellular backbone composed of the last 10 residues (represented in blue and green 
according to the W6.48 orientation.  In the center of the figure 11 B., all of the output helices 
from Starting Structure I and II are superimposed on the extracellular end showing that the two 
populations from Starting Structure I wobble in opposite direction from Starting Structure II.  In 
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part C. of the figure 11 the same helices as in B are shown when viewed from the intracellular 
side. 
 
Figure 12. Wild type CB2 TMH6 results from Starting Structure I and II runs. 
 
In Figure 12 A and B show the results of the WT CB2 TMH6 runs in Starting 
Conformation I and II, using AMBER* force field.  The output helices for each run are 
superimposed on their extracellular ends starting with the backbone atoms of the Proline residue 
and moving up towards the end of the helix.  Starting Structure II resulted in a higher population 
of W6.48 = trans (see Table 1). 
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Figure 13. L6.44F CB2 TMH6 mutant results from Starting Structure I runs. 
 
 In the above Figure 13 A and B the results shown include only the Starting Structure I 
runs since the same findings were obtained when Starting Structure II was used. 
Again the force field employed was AMBER*.  The output helices for each run are 
superimposed on their extracellular ends starting with the backbone atoms of the Proline residue 
and moving up towards the end of the helix. The figure illustrates that when F6.44 is in a trans 
conformation, it favors a W6.48 trans , while when F6.44 is in a g+ , it overwhelmingly 
favors a W6.48 g+ . 
When the human WT CB2 TMH6 was run in a similar way but using the CHARMM 
force field instead of the AMBER*, the percent of of W6.48 in trans (active state) was 20%, 
which is consistent with the Conformational Memories run on the same helix using the Amber * 
force field.  However, due to other unpublished results of experiments done in Reggio‟s lab in 
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which CHARMM force field runs gave better results, this was the force field chosen for the CM 
runs in Specific Aim 2 for GPR55 helices.  
 In conclusion, the bend, wobble and face shift showed dependency on the starting 
conformation of the helix in a consistent manner.  The Starting Structure II helices were more 
bent than the ones obtained from the Starting Structure I and they were over-wound as a result of 
this bend, while the ones from the Starting Structure I were under-wound (negative face shift 
values), such that the helices from the rhodopsin template (II) twist away from the W6.48, while 
the ones build from Macromodel twist over the tryptophan. However, regardless of the starting 
structure, the bend was slightly higher in the helices with W6.48 in the trans configuration.  The 
wobble and face shift varied only slightly within a Starting Structure set, according to the W6.48 
angle or according to wild type vs. mutated helices.  The W6.48 population was different 
between Starting Structure I with it being predominantly g+, while Starting Structure II generated 
similar percentages of g+ and trans. 
 
3.1.2 Experimental Results (Collaborator) 
The following experimental results were obtained in Dr Zhao-Hui Song‟s lab at 
University of Louisville School of Medicine. 
 
Table 2. Competition of specific [
3
H]-CP-55940 binding to wild type and mutant CB2 receptor by 
CP55940 and SR144528. CI: Confidence Interval 
Type 
CP55940 SR144528 
Kd (95%Cl), nM n Ki(95%Cl), nM n 
CB2 wild type 0.79(0.39-1.62) 10 14.8(9.49-23.3) 7 
CB2 L644F mutant 4.47(1.38-14.5) 6 55.0(52.0-58.2) 3 
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Adenylyl cyclase is an enzyme that catalyzes the conversion of ATP to cAMP.  CB2 
receptors couple to Gi/o proteins that inhibit the enzyme adenylyl cyclase, thus decreasing the 
levels of cAMP.   In this study, forskolin, which is able to activate adenylate cyclase by itself, 
was used in order to raise the levels of cAMP and resensitizing the cell receptors.  Because CB2 
receptors are constitutively active (CA), they reduce the cAMP levels in the absence of agonists.  
If an antagonist is added, such as SR144528, the activity of the cannabinoid receptor is reduced 
and therefore its effects on adenylyl cyclase are diminished and the levels of cAMP increase.  If 
the receptor is not present though, the addition of the antagonist has no effect on the levels of 
cAMP.   This is observed in Figure 14 A in which CB2 receptor was present and the levels of 
cAMP increase when the antagonist was added, thus preventing the cannabinoid receptor from 
inhibiting adenylyl cyclase.  In contrast, in Figure 14B in which there is no CB2 present, the 
addition of the antagonist has no effect on the cAMP levels.  Once the existence of the receptor 
was verified, Figure 15 shows that the L6.44F mutant has lost its constitutive activity and the 
addition of antagonist had no effect on the levels of cAMP.  
 In Figure 14 A CB2 inverse agonist (1mM), SR144528, prevented wild type CB2 
receptor from decreasing cAMP level.  In contrast, SR144528 had no such effect in untransfected 
HEK293 cells. 
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Figure 14. Constitutive activity of the wild type CB2 receptor.  
 
Experimental results for CB2 L6.44F show that while CP55940 has similar affinity for 
WT CB2 vs. the L6.44F mutant (see Table 2), the affinity of SR144528 at L6.44F is diminished 
3.7 fold relative to WT.  This decrease in affinity is unexpected since the L6.44F mutant shows 
reduced CA (constitutive activity), indicating the receptor population is in the “off” state, the state 
for which SR has higher affinity.  It may be that the L6.44F mutation has had an effect on the 
SR144528 binding pocket and consequently, this results in reduced SR affinity.  
 Figure 14A shows that WT CB2 is a constitutively active (CA) receptor.  Consequently, a 
preference for the W6.48  = trans state would be expected for the WT receptor. CM 
calculations of WT CB2 TMH6 (Starting Structure II) revealed a preference for the W6.48  1 = 
trans (activated) state conformation, while calculations with (Starting Structure I) did not. Taken 
together these results suggest that CM runs should employ an initial Rho template for the Starting 
Conformation of the helices. 
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Figure 15. SR144528 did not affect the basal level of cAMP in the L6.44F mutant, indicating reduced 
constitutive activity for this mutant. 
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 Figures 15 shows that the L6.44F mutant (Figure 15) has greatly diminished constitutive 
activity compared to WT (see Figure 13, left). These results are consistent with the modeling 
results presented here, which suggest that the 1 of residue 6.44 influences the 1 of W6.48 (see 
Table 1).  Since in the context of the full CB2 bundle, an F at 6.44 can only exist in a 1 = g+ 
(Hurst, Grossfield et al. 2010), the modeling studies suggest that W6.48 will remain in the 1 = g+ 
(inactive state). This, in turn, should result in diminished constitutive activity in the mutant. 
 
3.2 Specific Aim 2: Refinement of R State Model of GPR55 
The GPR55 model was first refined based on computational refinements of the models.  
The initial model of GPR55 reported here in the Introduction section (Figure 6) is based upon a 
rhodopsin (Rho) template (1GZM structure).  As mentioned previously, from Reggio‟s work with 
CB1/CB2, although the rhodopsin crystal structure is a good starting point for the cannabinoid 
receptor modeling, there are sequence dictated differences between rhodopsin and each of these 
receptors.  These differences can be manifested by the absence of a key motif, by divergent 
locations of proline or glycine residues, as well as by the presence of serines or threonines at key 
 
 
44 
positions, which can have important effects upon helix conformations.  The biased Monte 
Carlo/simulated annealing Conformational Memories method, which was selected in Specific 
Aim 1 and described in the Research and Design Methods section, was used to study such 
sequence dictated divergences in key helices from the Rho template in GPR55.  This technique 
has been successfully used previously to identify important differences from Rho in TMH6 of 
CB1 and CB2  (Barnett-Norris, Hurst et al. 2002) and to demonstrate a divergence in the TMH2 
structure of CB2 from that of Rho (Zhang, Hurst et al. 2005).  
 Conformational Memories (CM) calculations for the GPR55 transmembrane helices were 
performed using a rhodopsin template starting conformation of the helices and the CHARMM 
force field.  (1)  TMH2. The first helix studied was TMH2, which in Rho does not have a proline, 
but does have a helix distortion from G2.56 to T2.59 (GGFT).  The GGFT sequence is not found 
in GPR55, but the proline at 2.58 could mimic the structural distortion of the GGFT.  Therefore 
the flexible region was considered to be from V2.54 to P2.58 (GPR55).  (2) TMH5. The next 
important helix to study was TMH5.  In Rho, there is a single proline residue in TMH5 at position 
5.50, which causes a deviation from normal alpha-helicity in the region, 5.46-5.50.  TMH5 in 
GPR55, however, has two proline residues (P5.40 and P5.50) and three glycine residues (G5.46, 
G5.52 and G5.55), which also could cause distortions from normal alpha-helicity.  For this reason 
the possibility of three regions of flexibility in this helix were considered: K5.37- P5.41 
(KVFFP), G5.46-P5.50 (GFLLP), and M5.51-G5.55 (MGIMG).  (3) TMH6. The next helix 
considered was TMH6, which in GPR55 does not have the highly conserved CWXP motif, so 
typical of the Class A GPCR, but has the conservative substitutions of this motif: SFLP in 
GPR55.  Because this helix has been implicated in conformational changes during receptor 
activation, it was important to study the allowed conformations of this helix by considering the 
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region from V6.46 to P6.50 as the flexible part.  (4)  TMH7. Lastly, the TMH7 helix was studied 
considering the C7.46 to V7.50 (CCLDV) region as the flexible region.   
 The CM results for TMH2, 5, 6 and 7 are presented in Table 3 and Figures 16-19 below. 
 
Table 3. Summary of the Average Bend, Wobble, and Face Shift angle results for GPR55 TMH2, TMH5, 
and TMH6 runs. 
GPR55     Average Bend  Average Wobble Average Face Shift  
  (B)  (W)  (FS) 
TMH2 (V2.54-P2.58) 25.72 -112.97 25.30 
TMH5 (K5.37-P5.41) 8.23 82.80 9.02 
TMH5 (G5.46-P5.50) 11.97 -113.36 66.42 
TMH5 (M5.51-G5.55) 7.86 1.53 14.16 
TMH6 (V6.46-P6.50) 24.85 -105.24 51.93 
 
The TMH7 output structures obtained were highly bent and not suited to be used in the 
receptor model; therefore the statistical data for TMH7 is not included in the table above (see 
Figure 16). 
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Figure 16. CM results for TMH7 of GPR55.  
 
Figure 17. CM results for TMH2, TMH5, and TMH6 of GPR55.  
 
In Figure 17, the output structures for each helix run are superimposed intracellularly and 
placed in the context of our GPR55 model described in the Introduction section (see Figure 6).   
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Figure 18. CM results for TMH2, TMH5, TMH6 and TMH7 of GPR55 
 
 
Figure 18 illustrates the extracellular view of the conformational memories results for 
TMH2 (green), TMH5 (red/orange/yellow), TMH6 (cyan) and TMH7 (magenta) of GPR55 (A) 
and side views in B and C.  As in Figure 17, the output structures for each helix run are 
superimposed intracellularly and placed in the context of our GPR55 model described in the 
Introduction section (see Figure 6). 
TMH2  
From Figures 16 -17 above, it can be seen that the TMH2 population wobbles toward 
TMH3 when compared to the rhodopsin template.  Extracellular loop EC1 between TMH3 and 
TMH2 is 3 residues shorter in GPR55 than in Rhodopsin, so TMH2 helices that reach over 
towards TMH3 would be preferred for use in a GPR55 model.   
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Figure 19. CM results for each of the region varied in TMH5. 
 
TMH5 
Similarly, from Figures 16-18, it can be seen that TMH5 population bends away from the 
template transmembrane helix bundle.  This is true no matter which region of TMH5 is treated as  
flexible (see Figure 18).   
TMH6 
The helices obtained from CM calculations show that the TMH6 population leans toward 
the TMH5 at the extracellular end.  By comparing the sequence of rhodopsin and GPR55, it can 
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be noted that the extracellular loop 3 (EC3) has eight extra residues in GPR55 
(RNSFIVECRAKQSI) compared to Rho (QGSDFG) , thus allowing GPR55 TMH6 to lean 
further away from TMH7 and closer to TMH5.   
TMH7 
The results for TMH7 were unusable because none of the helices could fit in context of 
full bundle due to high bend angles.  This was possible since the calculations were run in vacuum 
and not in the context of a bundle. 
The results of these Conformational Memories calculations will be used to refine the 
current GPR55 model.  There are other regions of the GPR55 sequence that may also diverge 
from the Rho structure.  For example, serine and threonine residues can also bend helices.  We 
will not pursue the hypothesis that a Ser or Thr may be altering helix conformation, however, 
until we have experimental mutation results that might suggest a distortion in a given helix 
relative to the current model.  For example, in TMH3, the region SMYGS, from 3.35-3.39 and in 
TMH4, the region WTGSIP, from 4.54-4.59, would be possible flexible regions that could be 
studied in the future.  TMH1 is largely pushed away from the binding pocket in Class A GPCRs.  
In GPR55 TMH1, the region from 1.37-1.41 (AVHIP) would be another region that likely 
influences the helix conformation. 
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